If the patient is not well tolerating the maintenance dose, it can be brought down to 1.7 mg as per the dose-escalation above
A compound that simultaneously activates three distinct receptor types, in Retatrutides case the GLP-1, GIP, and glucagon receptors
Clinical studies elucidating the effects of antidiabetic agents, including GLP-1R agonists, DPP4-inhibitors and metformin, on the development and progression of ocular conditions
Ultrasound of the brachial plexus
Vitamin injections last anywhere from a few weeks to 1 month
In healthy individuals, GLP-1 enhances insulin secretion and suppresses GCG release in response to nutrient intake